Valuation : Berkley Renewables Inc.

Market Cap 364K 314K 295K 269K 505K 34.67M 509K 3.49M 1.36M 17.58M 1.37M 1.34M 58.22M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.41M 4.14M 3.78M 7.11M 488M 7.16M 49.1M 19.1M 247M 19.25M 18.83M 819M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 2002-06-19
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 2006-08-16
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
+1.64%-0.64%+33.87%+11.31% 159B
+1.98%-1.11%+57.54%+58.98% 103B
+1.12%-3.50%+16.14%+12.70% 76.04B
+1.83%+0.12%+26.40%-4.16% 60.16B
+1.39%-0.11%+90.26%+65.26% 59.22B
+1.42%-2.49%+33.78%+32.09% 56.14B
+2.45%+0.58%+34.38%-5.05% 55.78B
+0.86%-2.33%+25.14%-11.67% 44.14B
-0.71%+0.73%+4.51%+25.36% 33.89B
Average +1.20%-1.27%+35.78%+20.54% 64.79B
Weighted average by Cap. +1.41%-1.38%+37.93%+22.13%

Financials

2016 2017
Net sales 1.03M 890K 836K 763K 1.43M 98.39M 1.44M 9.91M 3.85M 49.89M 3.88M 3.8M 165M 1.72M 1.49M 1.39M 1.27M 2.39M 164M 2.41M 16.52M 6.43M 83.22M 6.48M 6.34M 276M
Net income 173K 149K 140K 127K 239K 16.43M 241K 1.65M 644K 8.33M 648K 634K 27.59M -631K -543K -510K -465K -874K -59.99M -880K -6.04M -2.35M -30.42M -2.37M -2.32M -101M
Net Debt 2.92M 2.51M 2.36M 2.15M 4.04M 278M 4.07M 27.95M 10.87M 141M 10.95M 10.71M 466M 4.76M 4.1M 3.85M 3.51M 6.6M 453M 6.65M 45.61M 17.75M 230M 17.88M 17.49M 761M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-